Skip to main content
. 2020 Jan 8;10(1):3. doi: 10.1038/s41408-019-0270-0

Fig. 1. p38β is overexpressed in AML and its inhibition decreases SET protein levels, increasing PP2A activity.

Fig. 1

a HL60 and MOLM-13 cell lines were treated with the p38 inhibitors SB203580 (2.5 µM) and PH797804 (250 nM) for 24 h. Protein expression for p-HSP27/HSP27 (p38 substrate) and SET was analyzed by western blot. b Measurement of PP2A activity after p38 inhibition by immunoprecipitation and phosphatase assay. c Silencing of p38α and p38β with specific siRNA (50 nM for 48 h), and analysis of total protein by western blot. d Measurement of PP2A activity by immunoprecipitation and phosphatase assay. e Western blot analysis of total protein in AML cell lines and AML patient samples, compared to peripheral blood mononuclear cells (PB-MC). The results are corrected by the specific loading control and are expressed as fold-change of the control, which are assigned a value of 1 and are mean values. Experiments were performed in triplicate four times. *p < 0.05.